Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities
Barbara Bosier, Giulio G. Muccioli, Emmanuel Hermans, et al.
Biochemical Pharmacology (2010) Vol. 80, Iss. 1, pp. 1-12
Closed Access | Times Cited: 181

Showing 1-25 of 181 citing articles:

The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
S P H Alexander, Helen E. Benson, Elena Faccenda, et al.
British Journal of Pharmacology (2013) Vol. 170, Iss. 8, pp. 1459-1581
Open Access | Times Cited: 552
From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
Alessia Ligresti, Luciano De Petrocellis, Vincenzo Di Marzo
Physiological Reviews (2016) Vol. 96, Iss. 4, pp. 1593-1659
Open Access | Times Cited: 414
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
Debra A. Kendall, Guillermo A. Yudowski
Frontiers in Cellular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 304
CB 1 and CB 2 Receptor Pharmacology
A­llyn C. Howlett, Mary E. Abood
Advances in pharmacology (2017), pp. 169-206
Open Access | Times Cited: 294
Amygdala FAAH and anandamide: mediating protection and recovery from stress
Ozge Gunduz‐Cinar, Matthew N. Hill, Bruce S. McEwen, et al.
Trends in Pharmacological Sciences (2013) Vol. 34, Iss. 11, pp. 637-644
Open Access | Times Cited: 210
Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association
Robert L. Page, Larry A. Allen, Robert A. Kloner, et al.
Circulation (2020) Vol. 142, Iss. 10
Open Access | Times Cited: 179
Cannabinoid and opioid interactions: Implications for opiate dependence and withdrawal
Jillian L. Scavone, Robert C. Sterling, Elisabeth J. Van Bockstaele
Neuroscience (2013) Vol. 248, pp. 637-654
Open Access | Times Cited: 185
Cannabinoids as therapeutic agents in cancer: current status and future implications
Bandana Chakravarti, Janani Ravi, Ramesh K. Ganju
Oncotarget (2014) Vol. 5, Iss. 15, pp. 5852-5872
Open Access | Times Cited: 183
Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons
Robert B. Laprairie, Amina M. Bagher, Michael E. Kelly, et al.
Journal of Biological Chemistry (2014) Vol. 289, Iss. 36, pp. 24845-24862
Open Access | Times Cited: 133
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
Sandeep Vasant More, Dong‐Kug Choi
Molecular Neurodegeneration (2015) Vol. 10, Iss. 1
Open Access | Times Cited: 133
Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies
Sabine Steffens, Pál Pacher
British Journal of Pharmacology (2012) Vol. 167, Iss. 2, pp. 313-323
Open Access | Times Cited: 123
Activation of cannabinoid receptors by the pentacyclic triterpene α,β-amyrin inhibits inflammatory and neuropathic persistent pain in mice
Kathryn A.B. Simão da Silva, Ana F. Paszcuk, Giselle F. Passos, et al.
Pain (2011) Vol. 152, Iss. 8, pp. 1872-1887
Closed Access | Times Cited: 121
Human lung-resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factors
Rosaria Ilaria Staiano, Stefania Loffredo, Francesco Borriello, et al.
Journal of Leukocyte Biology (2015) Vol. 99, Iss. 4, pp. 531-540
Open Access | Times Cited: 113
The K2/Spice Phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products
Lisa K. Brents, Paul L. Prather
Drug Metabolism Reviews (2013) Vol. 46, Iss. 1, pp. 72-85
Open Access | Times Cited: 110
CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
Gemma L. Baillie, James G. Horswill, Sharon Anavi‐Goffer, et al.
Molecular Pharmacology (2012) Vol. 83, Iss. 2, pp. 322-338
Open Access | Times Cited: 110
Neuron‐type specific cannabinoid‐mediated G protein signalling in mouse hippocampus
Frauke Steindel, Raissa Lerner, Martin Häring, et al.
Journal of Neurochemistry (2013) Vol. 124, Iss. 6, pp. 795-807
Closed Access | Times Cited: 104
A Guide to Targeting the Endocannabinoid System in Drug Design
Adam Stasiulewicz, Katarzyna Znajdek, Monika Grudzień, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2778-2778
Open Access | Times Cited: 102
Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation
János Pálóczi, Zoltán V. Varga, George Hasko, et al.
Antioxidants and Redox Signaling (2017) Vol. 29, Iss. 1, pp. 75-108
Open Access | Times Cited: 97
Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists
Elise Wouters, Jolien Walraed, Samuel D. Banister, et al.
Biochemical Pharmacology (2019) Vol. 169, pp. 113623-113623
Closed Access | Times Cited: 79
Synthesis and in Vitro Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A-CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICA
Annelies Cannaert, Eric Sparkes, Edward Pike, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 24, pp. 4434-4446
Closed Access | Times Cited: 79
New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
Berhanu Geresu Kibret, Hiroki Ishiguro, Yasue Horiuchi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 975-975
Open Access | Times Cited: 45
Extracellular ubiquitin: immune modulator and endogenous opponent of damage-associated molecular pattern molecules
Matthias Majetschak
Journal of Leukocyte Biology (2010) Vol. 89, Iss. 2, pp. 205-219
Closed Access | Times Cited: 107
Ligand-Dependent Conformations and Dynamics of the Serotonin 5-HT2A Receptor Determine Its Activation and Membrane-Driven Oligomerization Properties
Jufang Shan, George Khelashvili, Sayan Mondal, et al.
PLoS Computational Biology (2012) Vol. 8, Iss. 4, pp. e1002473-e1002473
Open Access | Times Cited: 103
Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids
Emma Puighermanal, Arnau Busquets‐Garcia, Rafaël Maldonado, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2012) Vol. 367, Iss. 1607, pp. 3254-3263
Open Access | Times Cited: 95
The CXC Chemokine Receptor 4 Ligands Ubiquitin and Stromal Cell-derived Factor-1α Function through Distinct Receptor Interactions
Vikas Saini, Daniel M. Staren, Joshua J. Ziarek, et al.
Journal of Biological Chemistry (2011) Vol. 286, Iss. 38, pp. 33466-33477
Open Access | Times Cited: 89
Page 1 - Next Page

Scroll to top